Sources | Names Used |
---|---|
CTRPv2 | tretinoin:navitoclax (4:1 mol/mol) |
PharmacoGx | tretinoin:navitoclax (4:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | KRTAP16-1 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
mRNA | VIPAS39 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
mRNA | DLG3 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |
mRNA | ZNF593 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.003 |
mRNA | MOAP1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
mRNA | GPATCH1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
mRNA | SLC39A1 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
mRNA | ZNF836 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
mRNA | PARD3B | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
mRNA | ACBD6 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.003 |